115 related articles for article (PubMed ID: 14700415)
1. Roseomonas infection associated with a left ventricular assist device.
Singal A; Malani PN; Day LJ; Pagani FD; Clark NM
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):963-5. PubMed ID: 14700415
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates.
Wang CM; Lai CC; Tan CK; Huang YC; Chung KP; Lee MR; Hwang KP; Hsueh PR
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):199-203. PubMed ID: 22209515
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage.
Nolan JS; Waites KB
J Infect; 2005 Apr; 50(3):244-51. PubMed ID: 15780421
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.
Michon AL; Saumet L; Bourdier A; Haouy S; Sirvent N; Marchandin H
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e165-8. PubMed ID: 23669726
[TBL] [Abstract][Full Text] [Related]
5. Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review.
Tsai SF; Chen CH; Shu KH; Wu MJ
Intern Med; 2012; 51(13):1721-4. PubMed ID: 22790133
[TBL] [Abstract][Full Text] [Related]
6. Chronic postoperative Roseomonas endophthalmitis.
Chen KJ; Lai CC; Kuo YH; Wu WC; Chen TL
J Clin Microbiol; 2009 Jan; 47(1):266-7. PubMed ID: 18987177
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Roseomonas gilardii Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis.
Malini S; Goh BL; Lim TS
Perit Dial Int; 2016 Sep; 36(5):578. PubMed ID: 27659935
[No Abstract] [Full Text] [Related]
8. Catheter-related bacteremia due to Roseomonas species in pediatric hematology/oncology patients.
McLean TW; Rouster-Stevens K; Woods CR; Shetty AK
Pediatr Blood Cancer; 2006 Apr; 46(4):514-6. PubMed ID: 15782406
[TBL] [Abstract][Full Text] [Related]
9.
Ioannou P; Mavrikaki V; Kofteridis DP
J Chemother; 2020 Sep; 32(5):226-236. PubMed ID: 32619387
[No Abstract] [Full Text] [Related]
10. Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental.
Romano-Bertrand S; Bourdier A; Aujoulat F; Michon AL; Masnou A; Parer S; Marchandin H; Jumas-Bilak E
Clin Microbiol Infect; 2016 Aug; 22(8):737.e1-7. PubMed ID: 27269884
[TBL] [Abstract][Full Text] [Related]
11. Roseomonas bacteremia in a recipient of an allogeneic hematopoietic stem cell transplantation.
Al-Anazi KA; AlHashmi H; Abdalhamid B; AlSelwi W; AlSayegh M; Alzayed A; Alshibani Z; AlGarni A; Al-Ghanem A; Hassan H; AlSagheir A
Transpl Infect Dis; 2013 Aug; 15(4):E144-7. PubMed ID: 23725464
[TBL] [Abstract][Full Text] [Related]
12. Roseomonas gilardii subsp rosea, a pink bacterium associated with bacteremia: the first case in Thailand.
Srifuengfung S; Tharavichitkul P; Pumprueg S; Tribuddharat C
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):886-91. PubMed ID: 18041307
[TBL] [Abstract][Full Text] [Related]
13. A nosocomial cluster of Roseomonas mucosa bacteremia possibly linked to contaminated hospital environment.
Okamoto K; Ayibieke A; Saito R; Ogura K; Magara Y; Ueda R; Ogawa H; Hatakeyama S
J Infect Chemother; 2020 Aug; 26(8):802-806. PubMed ID: 32265107
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer.
Dé I; Rolston KV; Han XY
Clin Infect Dis; 2004 Jun; 38(11):1579-84. PubMed ID: 15156446
[TBL] [Abstract][Full Text] [Related]
15. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device.
D'Ancona G; Pasic M; Buz S; Drews T; Dreysse S; Hetzer R; Unbehaun A
Ann Thorac Surg; 2012 Apr; 93(4):e89-91. PubMed ID: 22450111
[TBL] [Abstract][Full Text] [Related]
16. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
[TBL] [Abstract][Full Text] [Related]
17. Pathological analysis of the aortic valve after long-term left ventricular assist device support.
Hata H; Fujita T; Ishibashi-Ueda H; Nakatani T; Kobayashi J
Eur J Cardiothorac Surg; 2014 Aug; 46(2):193-7. PubMed ID: 24335262
[TBL] [Abstract][Full Text] [Related]
18. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
[TBL] [Abstract][Full Text] [Related]
19. The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam.
Dervisoglou A; Tsiodras S; Kanellakopoulou K; Pinis S; Galanakis N; Pierakakis S; Giannakakis P; Liveranou S; Ntasiou P; Karampali E; Iordanou C; Giamarellou H
Arch Surg; 2006 Dec; 141(12):1162-7. PubMed ID: 17178957
[TBL] [Abstract][Full Text] [Related]
20. Hemolysis from aortic regurgitation mimicking pump thrombosis in a patient with a HeartMate II left ventricular assist device: a case report.
Gopalan RS; Arabia FA; Noel P; Chandrasekaran K
ASAIO J; 2012; 58(3):278-80. PubMed ID: 22285976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
